Page last updated: 2024-10-21

phenytoin and Granulocytic Leukemia, Chronic

phenytoin has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Here we present the case of a chronic myeloid leukemia patient with an inadequate response to imatinib due to concurrent phenytoin administration."1.51Inadequate response to imatinib treatment in chronic myeloid leukemia due to a drug interaction with phenytoin. ( Díez, JL; Escudero-Vilaplana, V; García-González, X; Gómez-Centurión, I; González-Arias, E; Osorio, S, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Osorio, S1
Escudero-Vilaplana, V1
Gómez-Centurión, I1
González-Arias, E1
García-González, X1
Díez, JL1

Other Studies

1 other study available for phenytoin and Granulocytic Leukemia, Chronic

ArticleYear
Inadequate response to imatinib treatment in chronic myeloid leukemia due to a drug interaction with phenytoin.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019, Volume: 25, Issue:3

    Topics: Aged, 80 and over; Antineoplastic Agents; Cytochrome P-450 CYP3A; Drug Interactions; Drug Resistance

2019